Cost evaluation of gadoxetic acid-enhanced magnetic resonance imaging in the diagnosis of colorectal-cancer metastasis in the liver: Results from the VALUE Trial. - Wikidata - wikimedia - TriplyDB

Cost evaluation of gadoxetic acid-enhanced magnetic resonance imaging in the diagnosis of colorectal-cancer metastasis in the liver: Results from the VALUE Trial.

Cost evaluation of gadoxetic acid-enhanced magnetic resonance imaging in the diagnosis of colorectal-cancer metastasis in the liver: Results from the VALUE Trial.

http://www.wikidata.org/entity/Q37314146

about

Extracellular contrast agent-enhanced MRI: 15-min delayed phase may improve the diagnostic performance for hepatocellular carcinoma in patients with chronic liver disease.Health economic assessment of Gd-EOB-DTPA MRI versus ECCM-MRI and multi-detector CT for diagnosis of hepatocellular carcinoma in China.

P2860

Q47603110-BEC1A9B5-622E-47A9-BEB5-006AA5A63155 Q48259378-571F2945-3767-43D3-99E1-D5B866A47541

P2860

Cost evaluation of gadoxetic acid-enhanced magnetic resonance imaging in the diagnosis of colorectal-cancer metastasis in the liver: Results from the VALUE Trial.

http://www.wikidata.org/entity/Q37314146

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 February 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cost evaluation of gadoxetic a ...... Results from the VALUE Trial.

@en

Cost evaluation of gadoxetic a ...... Results from the VALUE Trial.

@nl

type

label

Cost evaluation of gadoxetic a ...... Results from the VALUE Trial.

@en

Cost evaluation of gadoxetic a ...... Results from the VALUE Trial.

@nl

prefLabel

Cost evaluation of gadoxetic a ...... Results from the VALUE Trial.

@en

Cost evaluation of gadoxetic a ...... Results from the VALUE Trial.

@nl

P1433

Q37314146-439B4490-9F00-40CF-8091-41D459020F80

P1476

Q37314146-42C1FC0C-D48F-489D-A47C-A6B985A793B0

P2093

Q37314146-3A010F11-8D17-472A-8CB5-61497CA79104

Q37314146-47A5FB72-D293-4EE9-A9D5-C11BF57502AA

Q37314146-6F1D4732-40EF-4AA7-8950-0378AA000701

Q37314146-7B07BDD3-FB54-4961-B536-13C17F0C69AB

Q37314146-AD8D2E90-43ED-4AB7-9F92-CDFC9DAB00D9

Q37314146-BE0387F5-B106-4F8B-A7DF-BDD364831808

P2860

Q37314146-096065B0-3FE9-4A1C-B786-AC97EA5FEBE2

Q37314146-0C6CA268-6617-4B14-87AA-A253BDC2B4D0

Q37314146-0EF03CA4-F416-4962-B75A-8A86608FD5DA

Q37314146-225FBE81-C7AF-4CF2-AF62-DDFD269DDFBD

Q37314146-321375AF-44E2-43CF-A38B-7E93977C9507

Q37314146-3719AED2-14D3-478B-8885-96BFD0E8EF73

Q37314146-40E2B13C-B162-4929-AA51-4A09446FED7D

Q37314146-640078CA-654D-404F-834A-1D5108A488BF

Q37314146-6A7E4E4C-F8E3-4EF4-A66A-23644ADD56C7

Q37314146-7A995B4F-5D0D-4171-A9D9-663AE9632FFB

P2888

Q37314146-754FE565-5709-4689-970C-8DD3637FD496

P304

Q37314146-41DE2FDC-ADC9-46D7-9173-6B6583AA4614

P31

Q37314146-F6DF3922-DF38-4F04-9228-FD385E6C841F

P356

Q37314146-403ABA3D-0721-4A62-8C22-CEFD3BB42B31

P407

Q37314146-B1D816B7-8C33-4D40-8B80-584F8F84D3A7

P433

Q37314146-E9A25E90-9144-455F-8F1B-C20E0FAF170B

P478

Q37314146-788A34A1-6382-494B-A1E3-D9BA5110127E

P50

Q37314146-C896CB38-A43C-4CB2-B914-61FD04211C59

P577

Q37314146-DFC01F43-44B6-4461-88F3-1D026FFCD7F3

P5875

Q37314146-89879D6E-D881-4EE8-BA9B-F7F0F205149B

P698

Q37314146-03DA883A-7015-4104-8E67-8058763ACD02

P932

Q37314146-74FC625C-BA4A-4865-81FB-D59D9947D75E

P356

S00330-016-4271-0

P1433

European Radiology

P1476

Cost evaluation of gadoxetic a ...... Results from the VALUE Trial.

@en

P2093

Ahmed Ba-Ssalamah

http://www.w3.org/2001/XMLSchema#string

Andrea Lang

http://www.w3.org/2001/XMLSchema#string

Christoph J Zech

http://www.w3.org/2001/XMLSchema#string

Harald Rinde

http://www.w3.org/2001/XMLSchema#string

Myeong-Jin Kim

http://www.w3.org/2001/XMLSchema#string

Nahila Justo

http://www.w3.org/2001/XMLSchema#string

P2860

Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging

Trends in long-term survival following liver resection for hepatic colorectal metastases.

Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases.

Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment.

Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors.

Randomized multicentre trial of gadoxetic acid-enhanced MRI versus conventional MRI or CT in the staging of colorectal cancer liver metastases.

Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings.

Detailed liver-specific imaging prior to pre-operative chemotherapy for colorectal liver metastases reduces intra-hepatic recurrence and the need for a repeat hepatectomy.

The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus.

ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents.

P2888

s00330-016-4271-0

P304

4121-4130

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00330-016-4271-0

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

295831538

http://www.w3.org/2001/XMLSchema#string

P698

26905871

http://www.w3.org/2001/XMLSchema#string

P932

5052297

http://www.w3.org/2001/XMLSchema#string